Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Emerg Med. 2012 Dec 21;44(5):910–918. doi: 10.1016/j.jemermed.2012.09.036

Table 5.

Association Between Vancomycin Levels* and Outcomes

Subtherapeutic Therapeutic Supratherapeutic p
HLOS ≥ 3 days, No. (%) 1070 (86.8) 287 (89.1) 338 (93.9) 0.001
Peak Creatinine, mg/dl, Mean (SD) 1.88 2.72 3.47 < 0.001
Death, No. (%) 69 (5.6) 28 (8.7) 59 (16.4) < 0.001

Data represents 1,915 patients with non-peak vancomycin levels checked. “Therapeutic” level is defined as 15–20 mcg/ml.

P value comparison between therapeutic vs. subtherapeutic and supratherapeutic